SCLERODERMA, LOCALIZED

Clinical trials for SCLERODERMA, LOCALIZED explained in plain language.

Never miss a new study

Get alerted when new SCLERODERMA, LOCALIZED trials appear

Sign up with your email to follow new studies for SCLERODERMA, LOCALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Completed 1

Cancer drug shows promise against rare Skin-Fibrosis disease

Disease control Completed

This study tested whether imatinib (Glivec), a drug used for certain cancers, can reduce severe skin hardening in people with scleroderma. 28 adults with advanced skin involvement received either imatinib or a placebo for 6 months. The main goal was to measure changes in skin thi…

Matched conditions: SCLERODERMA, LOCALIZED

Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control

Last updated May 26, 2026 08:57 UTC

SCLERODERMA, LOCALIZED

Get alerted when new SCLERODERMA, LOCALIZED trials appear

Cancer drug shows promise against rare Skin-Fibrosis disease